Founded in Stockholm, Sweden, in April 2020, as a direct response to the unprecedented challenges of the coronavirus pandemic, we at ABC Labs set out to establish rapidly scalable, state-of-the-art PCR and ELISA testing. As a crucial player in flattening the curve and saving lives, these tests continue to be our focus.
We currently analyze thousands of tests daily for both the Public Health Agency of Sweden and a number of regional and private healthcare providers. By creating affordable, accessible, readily available testing, we remain among the largest private actors supporting the Swedish strategy.
Tackling society-threatening diseases requires convenient, accessible testing and screening. Once the pandemic subsides, we intend to utilize our infrastructure to provide cost-effective essential diagnostics at scale for care providers, employers, and policymakers.
We create user-friendly sampling flows, constant connectivity between lab, care provider, and patient, and radical transparency regarding quality and efficiency.
Founded by Per Båtelson, Ahsan Amjad, Ola Winqvist, Maria Rankka, and Johannes Schildt, ABC Labs conducts all testing at a state-of-the-art lab at Biomedicum on Campus Solna.
A Laboratory For The Future
By challenging industry standards, we strive to become a leading and highly trusted European center for disease and pandemic management. From here on, we come prepared.
We are a full-service SARS-CoV-2 laboratory offering state-of-the-art automated assays for the detection of virus RNA, immune responses with specific IgG/IgA/IgM immunoglobulins against the nucleocapsid and the spike protein from SARS-CoV-2. We analyze spike protein specific T cell recognition to evaluate T cell memory and vaccine response.